<VariationArchive VariationID="2108816" VariationName="NM_201384.3(PLEC):c.1188_1192dup (p.Val398fs)" VariationType="Duplication" Accession="VCV002108816" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-29" DateCreated="2023-02-08" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2170574" VariationID="2108816">
      <GeneList>
        <Gene Symbol="PLEC" FullName="plectin" GeneID="5339" HGNC_ID="HGNC:9069" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>8q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="143915153" stop="143976745" display_start="143915153" display_stop="143976745" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="144989320" stop="145050912" display_start="144989320" display_stop="145050912" Strand="-" />
          </Location>
          <OMIM>601282</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_201384.3(PLEC):c.1188_1192dup (p.Val398fs)</Name>
      <CanonicalSPDI>NC_000008.11:143934068:CGATGCG:CGATGCGATGCG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>8q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="143934068" stop="143934069" display_start="143934068" display_stop="143934069" variantLength="5" positionVCF="143934068" referenceAlleleVCF="A" alternateAlleleVCF="ACGATG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="145008236" stop="145008237" display_start="145008236" display_stop="145008237" variantLength="5" positionVCF="145008236" referenceAlleleVCF="A" alternateAlleleVCF="ACGATG" />
      </Location>
      <ProteinChange>V425fs</ProteinChange>
      <ProteinChange>V384fs</ProteinChange>
      <ProteinChange>V398fs</ProteinChange>
      <ProteinChange>V535fs</ProteinChange>
      <ProteinChange>V366fs</ProteinChange>
      <ProteinChange>V376fs</ProteinChange>
      <ProteinChange>V402fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.10" sequenceAccession="NC_000008" sequenceVersion="10" change="g.145008239_145008243dup" Assembly="GRCh37">
            <Expression>NC_000008.10:g.145008239_145008243dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.11" sequenceAccession="NC_000008" sequenceVersion="11" change="g.143934071_143934075dup" Assembly="GRCh38">
            <Expression>NC_000008.11:g.143934071_143934075dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012492.1" sequenceAccession="NG_012492" sequenceVersion="1" change="g.47673_47677dup">
            <Expression>NG_012492.1:g.47673_47677dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000445.5" sequenceAccession="NM_000445" sequenceVersion="5" change="c.1269_1273dup">
            <Expression>NM_000445.5:c.1269_1273dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000436.2" sequenceAccession="NP_000436" sequenceVersion="2" change="p.Val425fs">
            <Expression>NP_000436.2:p.Val425fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001410941.1" sequenceAccession="NM_001410941" sequenceVersion="1" change="c.1267_1271dup">
            <Expression>NM_001410941.1:c.1267_1271dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001397870.1" sequenceAccession="NP_001397870" sequenceVersion="1" change="p.Val425Alafs">
            <Expression>NP_001397870.1:p.Val425Alafs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_201378.4" sequenceAccession="NM_201378" sequenceVersion="4" change="c.1146_1150dup" MANEPlusClinical="true">
            <Expression>NM_201378.4:c.1146_1150dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_958780.1" sequenceAccession="NP_958780" sequenceVersion="1" change="p.Val384fs">
            <Expression>NP_958780.1:p.Val384fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_201379.3" sequenceAccession="NM_201379" sequenceVersion="3" change="c.1122_1126dup">
            <Expression>NM_201379.3:c.1122_1126dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_958781.1" sequenceAccession="NP_958781" sequenceVersion="1" change="p.Val376fs">
            <Expression>NP_958781.1:p.Val376fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_201380.4" sequenceAccession="NM_201380" sequenceVersion="4" change="c.1599_1603dup">
            <Expression>NM_201380.4:c.1599_1603dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_958782.1" sequenceAccession="NP_958782" sequenceVersion="1" change="p.Val535fs">
            <Expression>NP_958782.1:p.Val535fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_201381.3" sequenceAccession="NM_201381" sequenceVersion="3" change="c.1092_1096dup">
            <Expression>NM_201381.3:c.1092_1096dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_958783.1" sequenceAccession="NP_958783" sequenceVersion="1" change="p.Val366fs">
            <Expression>NP_958783.1:p.Val366fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_201382.4" sequenceAccession="NM_201382" sequenceVersion="4" change="c.1188_1192dup">
            <Expression>NM_201382.4:c.1188_1192dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_958784.1" sequenceAccession="NP_958784" sequenceVersion="1" change="p.Val398fs">
            <Expression>NP_958784.1:p.Val398fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_201383.3" sequenceAccession="NM_201383" sequenceVersion="3" change="c.1200_1204dup">
            <Expression>NM_201383.3:c.1200_1204dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_958785.1" sequenceAccession="NP_958785" sequenceVersion="1" change="p.Val402fs">
            <Expression>NP_958785.1:p.Val402fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_201384.3" sequenceAccession="NM_201384" sequenceVersion="3" change="c.1188_1192dup" MANESelect="true">
            <Expression>NM_201384.3:c.1188_1192dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_958786.1" sequenceAccession="NP_958786" sequenceVersion="1" change="p.Val398fs">
            <Expression>NP_958786.1:p.Val398fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_201384.3(PLEC):c.1188_1192dup (p.Val398fs) AND multiple conditions" Accession="RCV003038051" Version="2">
        <ClassifiedConditionList TraitSetID="26576">
          <ClassifiedCondition DB="MedGen" ID="C3150989">Autosomal recessive limb-girdle muscular dystrophy type 2Q</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C2931072">Epidermolysis bullosa simplex 5B, with muscular dystrophy</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C2677349">Epidermolysis bullosa simplex 5C, with pyloric atresia</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C4225309">Epidermolysis bullosa simplex with nail dystrophy</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0432317">Epidermolysis bullosa simplex, Ogna type</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-03-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-03-19" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-08" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">20447487</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21109228</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23289980</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28824526</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301336</ID>
          <ID Source="BookShelf">NBK1157</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="26576" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5020" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">PLEC1-Related Epidermolysis Bullosa with Pyloric Atresia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epidermolysis bullosa simplex with pyloric atresia</ElementValue>
                <XRef ID="Epidermolysis+bullosa+simplex+with+pyloric+atresia/8319" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Epidermolysis bullosa simplex 5C, with pyloric atresia</ElementValue>
                <XRef ID="MONDO:0012807" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">EBS5C</ElementValue>
                <XRef Type="MIM" ID="612138" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">EBS-PA</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16991" />
                <XRef ID="16991" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301336</ID>
                <ID Source="BookShelf">NBK1157</ID>
              </Citation>
              <XRef ID="158684" DB="Orphanet" />
              <XRef ID="C2677349" DB="MedGen" />
              <XRef ID="MONDO:0012807" DB="MONDO" />
              <XRef Type="MIM" ID="612138" DB="OMIM" />
            </Trait>
            <Trait ID="2093" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Epidermolysis bullosa simplex, Ogna type</ElementValue>
                <XRef ID="Epidermolysis+Bullosa+Simplex%2C+Ogna+Type/2584" DB="Genetic Alliance" />
                <XRef ID="398071000" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pidermolysis bullosa simplex 5A, Ogna type</ElementValue>
                <XRef ID="MONDO:0007555" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA SIMPLEX 5A, OGNA TYPE</ElementValue>
                <XRef Type="MIM" ID="131950" DB="OMIM" />
                <XRef Type="Allelic variant" ID="601282.0005" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">EBS5A</ElementValue>
                <XRef Type="MIM" ID="131950" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">EBSO</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2148" />
                <XRef ID="2148" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Epidermolysis bullosa with pyloric atresia (EB-PA) is characterized by fragility of the skin and mucous membranes, manifested by blistering with little or no trauma; congenital pyloric atresia; and ureteral and renal anomalies (dysplastic/multicystic kidney, hydronephrosis/hydroureter, ureterocele, duplicated renal collecting system, absent bladder). The course of EB-PA is usually severe and often lethal in the neonatal period. Most affected children succumb as neonates; those who survive may have severe blistering with formation of granulation tissue on the skin around the mouth, nose, fingers, and toes, and internally around the trachea. However, some affected individuals have little or no blistering later in life. Additional features shared by EB-PA and the other major forms of EB include congenital localized absence of skin (aplasia cutis congenita) affecting the extremities and/or head, milia, nail dystrophy, scarring alopecia, hypotrichosis, contractures, and dilated cardiomyopathy.</Attribute>
                <XRef ID="NBK1157" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Epidermolysis Bullosa with Pyloric Atresia</Attribute>
                <XRef ID="NBK1157" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301336</ID>
                <ID Source="BookShelf">NBK1157</ID>
              </Citation>
              <XRef ID="79401" DB="Orphanet" />
              <XRef ID="C0432317" DB="MedGen" />
              <XRef ID="MONDO:0007555" DB="MONDO" />
              <XRef Type="MIM" ID="131950" DB="OMIM" />
            </Trait>
            <Trait ID="33603" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Epidermolysis bullosa simplex with nail dystrophy</ElementValue>
                <XRef ID="MONDO:0014661" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">EBS5D</ElementValue>
                <XRef Type="MIM" ID="616487" DB="OMIM" />
              </Symbol>
              <XRef ID="C4225309" DB="MedGen" />
              <XRef ID="MONDO:0014661" DB="MONDO" />
              <XRef Type="MIM" ID="616487" DB="OMIM" />
            </Trait>
            <Trait ID="1163" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA SIMPLEX AND LIMB-GIRDLE MUSCULAR DYSTROPHY</ElementValue>
                <XRef Type="MIM" ID="226670" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epidermolysa bullosa simplex and limb girdle muscular dystrophy</ElementValue>
                <XRef ID="Epidermolysa+Bullosa+Simplex+and+Limb+Girdle+Muscular+Dystrophy/2571" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Epidermolysis bullosa simplex 5B, with muscular dystrophy</ElementValue>
                <XRef ID="MONDO:0009181" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epidermolysis bullosa simplex with muscular dystrophy</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">EBS5B</ElementValue>
                <XRef Type="MIM" ID="226670" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">EB-MD</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2137" />
                <XRef ID="2137" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Epidermolysis bullosa simplex (EBS) is characterized by fragility of the skin (and mucosal epithelia in some instances) that results in non-scarring blisters and erosions caused by minor mechanical trauma. EBS is distinguished from other types of epidermolysis bullosa (EB) or non-EB skin fragility syndromes by the location of the blistering in relation to the dermal-epidermal junction. In EBS, blistering occurs within basal keratinocytes. The severity of blistering ranges from limited to hands and feet to widespread involvement. Additional features can include hyperkeratosis of the palms and soles (keratoderma), nail dystrophy, milia, and hyper- and/or hypopigmentation. Rare EBS subtypes have been associated with additional clinical features including pyloric atresia, muscular dystrophy, cardiomyopathy, and/or nephropathy.</Attribute>
                <XRef ID="NBK1369" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301543</ID>
                <ID Source="BookShelf">NBK1369</ID>
              </Citation>
              <XRef ID="257" DB="Orphanet" />
              <XRef ID="C2931072" DB="MedGen" />
              <XRef ID="MONDO:0009181" DB="MONDO" />
              <XRef Type="MIM" ID="226670" DB="OMIM" />
            </Trait>
            <Trait ID="15787" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Limb-girdle muscular dystrophy, type 2Q</ElementValue>
                <XRef ID="Muscular+dystrophy%2C+limb-girdle%2C+type+2q/8930" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive limb-girdle muscular dystrophy type 2Q</ElementValue>
                <XRef ID="MONDO:0013390" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 17</ElementValue>
                <XRef Type="MIM" ID="613723" DB="OMIM" />
                <XRef Type="Allelic variant" ID="601282.0010" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LGMDR17</ElementValue>
                <XRef Type="MIM" ID="613723" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12542" />
                <XRef ID="12542" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="254361" DB="Orphanet" />
              <XRef ID="C3150989" DB="MedGen" />
              <XRef ID="MONDO:0013390" DB="MONDO" />
              <XRef Type="MIM" ID="613723" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="6015035" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="16082617|MedGen:C3150989;C0432317;C4225309;C2677349;C2931072" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003327555" DateUpdated="2024-02-28" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20301336</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20447487</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21109228</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23289980</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28824526</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Val425Alafs*3) in the PLEC gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PLEC are known to be pathogenic (PMID: 20301336, 20447487, 21109228, 23289980, 28824526). For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with PLEC-related conditions. This variant is not present in population databases (gnomAD no frequency).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PLEC" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000008.10:g.145008236_145008237insCGATG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3150989" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0432317" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4225309" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2677349" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2931072" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="6015035" TraitType="Disease" MappingType="XRef" MappingValue="C2931072" MappingRef="MedGen">
        <MedGen CUI="C2931072" Name="Epidermolysis bullosa simplex 5B, with muscular dystrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6015035" TraitType="Disease" MappingType="XRef" MappingValue="C3150989" MappingRef="MedGen">
        <MedGen CUI="C3150989" Name="Autosomal recessive limb-girdle muscular dystrophy type 2Q" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6015035" TraitType="Disease" MappingType="XRef" MappingValue="C2677349" MappingRef="MedGen">
        <MedGen CUI="C2677349" Name="Epidermolysis bullosa simplex 5C, with pyloric atresia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6015035" TraitType="Disease" MappingType="XRef" MappingValue="C4225309" MappingRef="MedGen">
        <MedGen CUI="C4225309" Name="Epidermolysis bullosa simplex with nail dystrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6015035" TraitType="Disease" MappingType="XRef" MappingValue="C0432317" MappingRef="MedGen">
        <MedGen CUI="C0432317" Name="Epidermolysis bullosa simplex, Ogna type" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

